XML 13 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounting for Stock-Based Compensation
 9 Months Ended
Dec. 31, 2011
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Accounting for Stock-Based Compensation
Note 3:  Accounting for Stock-Based Compensation
 
        The Company records compensation expense associated with stock options and restricted stock in accordance with ASC Topic 718 (“Share Based Payment”).  The Company adopted the modified prospective transition method provided under ASC Topic 718.   The compensation expense related to all of the Company’s stock-based compensation arrangements is recorded as a component of general and administrative expenses.  The Company had no stock options outstanding under the PetMed Express, Inc. 1998 Stock Option Plan (“1998 Plan”) as of December 31, 2011, and 13,332 options outstanding at December 31, 2010.  No options have been issued since May 2005 and there was no unrecognized compensation expense related to vested stock option awards.  The 1998 Plan expired on July 31, 2008.  There were no stock option exercises for the quarter ended December 31, 2011.  For the nine months ended December 31, 2010 the Company received $252,000 upon the exercise of stock options and the income tax benefit from stock options exercised totaled approximately $124,000 for the nine months ended December 31, 2010.  The Company had 542,377 restricted common shares issued under the 2006 Employee Equity Compensation Restricted Stock Plan (“Employee Plan”) and 152,000 restricted common shares issued under the 2006 Outside Director Equity Compensation Restricted Stock Plan (“Director Plan”) at December 31, 2011, all shares of which were issued subject to a restriction or forfeiture period which will lapse ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being amortized over the three-year restriction period.  During the quarter ended December 31, 2011 no restricted shares were issued to any employees or outside directors of the Company.  For the quarters ended December 31, 2011 and 2010, the Company recognized $559,000 and $562,000, respectively, of compensation expense related to the Employee and Director Plans.  For the nine months ended December 31, 2011 and 2010, the Company recognized $1.7 million and $1.6 million, respectively, of compensation expense related to the Employee and Director Plans.  At December 31, 2011 and 2010, there was $3.0 million and $4.3 million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the next three years.